Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21
May 30, 2023
Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial
July 23, 2021
Related Post
-
-
ChromaDex to Participate in the LD Micro Invitational XIII
May 30, 2023
-
Palatin Presents Preclinical Diabetic Nephropathy Data at the International Podocyte Conference
May 30, 2023
-
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Expansion Portion of Acclaim-1 Clinical Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
May 30, 2023